Indigenous manufacture of biopharmaceuticals is severely limited in Africa which depends on imports for nearly 80% of its requirements. The foreign companies, who have developed vaccines for COVID-19, are enabling the Africa Union to launch a platform for partnerships that augurs well for drug production in Africa. The mission is to promote collaboration, investment, technology transfer, workforce development, and leverage governmental support to overcome the impediments of growth of achieving self-sufficiency of manufacturing in the continent.


Janet Byaruhanga

Senior Program Officer, Public Health, AUD-NEPAD

Dr. Prashant Yadav, Think-tank Fellow, Professor, & Researcher. CGDEV, INSEAD and Harvard Med. Supply Chains for Medical Products

Hala Audi, Chief Executive Officer, Unizima

Yogeeta Mangalani, Head of Strategy, Marketing & Product, Unizima

Stavros Nicolaou, Group Senior Executive, Strategic Trade Development, Aspen Pharmacare Holdings

Azuka Okeke, CEO, ARC_ESM, Nigeria

Palu Dhanani, Managing Director, Universal Corporation, Kenya

Dr. Nico Vandaele, Prof., Operations Research & Operations Management,

KU Leuven (Belgium)

Nick Bertrand Ntahokaja, Strategic Initiatives Advisor, Unizima (the Univercells Group)

Jean-Pierre Tai, Business Development Manager, Unizima (the Univercells Group)

Dr. Cheikh Tidiane Diagne, Head of Operations, diaTROPIX, Institut Pasteur de Dakar

Pie Harerimana, CEO, Rwanda Medical Supplies (RMS)

Inés Buki, USAID Country Director, USAID

Ben Leyka, Chief Executive officer, African Agricultural Council (South Africa)

Eric Santkin, Trade and Investment Commissioner, Belgium (based in Rwanda covering Rwanda, Burundi, and Ethiopia)

Vicki M. Chilton, Chief of Staff, Integrum Scientific

David Karia, Programs & Grants Manager, MedSource Group, Kenya

Blaise Ndome, Executive Director, African Pharmaceutical Distribution Association

Franck Toussaint, Managing Director, BSMA Europe

Devendra Mishra, Executive Director & Co-Founder, BSMA